SEC Form 4 · accession 0001209191-15-051475
HALOZYME THERAPEUTICS, INC. · HALO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kenneth J Kelley
Director
Period of report
Jun 5, 2015
Accepted (ET)
Jun 9, 2015 · 5:00 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001159036
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 5, 2015 | M | 10,000 | $4.94 | A | 218,051 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy Common Stock) | $4.94 | Jun 5, 2015 | M | 10,000 | D | May 6, 2009 | May 8, 2018 | Common Stock | 10,000 | 0 | D |